InDex Pharmaceuticals has announced that…
Nordic Life Science
Category
New Market
Ultomiris has been approved in…
Koselugo (selumetinib) has been approved…
Ranibizumab biosimilar is being launched…
Calquence, a next generation, selective…
The EpiShuttle is approved by…
Orion Corporation has signed a…
The company has submitted the…
Orientation Marketing has opened a…
The company’s TetraGraph-system has now…
AstraZeneca and Daiichi Sankyo’s Enhertu…
Patent, pricing, production, and partnerships…
NorthX Biologics is expanding into…
BioLamina has announced plans to…
The Rhode Island Department of…
Hansa Biopharma has announces that…